Sands Arthur T Insider Trades

Insider Trading History

Track insider trading activity for Sands Arthur T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $8.6M 562,500 shares
Last Trade
Feb 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.25M 562,500 shares
$16.45
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $6.88M 450,000 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.7M 450,000 shares
$17.12
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $12.2M 800,000 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.98M 800,000 shares
$8.72
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $6.85M 448,000 shares
Last Trade
Feb 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.85M 448,000 shares
$10.83
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $6.11M 400,000 shares
Last Trade
Aug 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.4M 400,000 shares
$18.50
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $4.58M 300,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.67M 300,000 shares
$18.89
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $2.29M 150,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.85M 150,000 shares
$38.97
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $2.29M 150,000 shares
Last Trade
Feb 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.85M 150,000 shares
$38.97
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $12.3M 804,170 shares
Last Trade
Oct 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.6M 804,170 shares
$26.91
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $0 0 shares
Last Trade
Jul 23, 2020 Sale
No data
No data
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $0 0 shares
Last Trade
Jul 23, 2020 Sale
No data
No data
$15.28
Nurix Therapeutics
Nurix Therapeutics NRIX
President, CEO
Holding Value $0 0 shares
Last Trade
Jul 23, 2020 Sale
No data
No data
$15.28
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $141k 74,000 shares
Last Trade
Feb 28, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$464k 37,000 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $2M 1,051,120 shares
Last Trade
Feb 28, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$439k 35,000 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $68.9k 36,250 shares
Last Trade
Feb 28, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$454k 36,250 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $200k 105,000 shares
Last Trade
Feb 28, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$439k 35,000 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $1.86M 979,120 shares
Last Trade
Feb 28, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$454k 36,250 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $1.93M 1,016,120 shares
Last Trade
Feb 28, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$464k 37,000 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $1.94M 1,021,329 shares
Last Trade
Feb 28, 2014 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$373k 29,791 shares
$12.53
$1.90
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
President & CEO
Holding Value $1.79M 942,870 shares
Last Trade
Feb 28, 2013 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$276k 20,034 shares
$13.79
$1.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up